CN101839918B - Method for detecting spiramycin and special enzyme-linked immunoassay kit thereof - Google Patents
Method for detecting spiramycin and special enzyme-linked immunoassay kit thereof Download PDFInfo
- Publication number
- CN101839918B CN101839918B CN 200910237822 CN200910237822A CN101839918B CN 101839918 B CN101839918 B CN 101839918B CN 200910237822 CN200910237822 CN 200910237822 CN 200910237822 A CN200910237822 A CN 200910237822A CN 101839918 B CN101839918 B CN 101839918B
- Authority
- CN
- China
- Prior art keywords
- spiramvcin
- enzyme
- antiantibody
- liquid
- haptens
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 238000000034 method Methods 0.000 title claims abstract description 40
- 238000002965 ELISA Methods 0.000 title abstract description 16
- ACTOXUHEUCPTEW-BWHGAVFKSA-N 2-[(4r,5s,6s,7r,9r,10r,11e,13e,16r)-6-[(2s,3r,4r,5s,6r)-5-[(2s,4r,5s,6s)-4,5-dihydroxy-4,6-dimethyloxan-2-yl]oxy-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-10-[(2s,5s,6r)-5-(dimethylamino)-6-methyloxan-2-yl]oxy-4-hydroxy-5-methoxy-9,16-dimethyl-2-o Chemical compound O([C@H]1/C=C/C=C/C[C@@H](C)OC(=O)C[C@@H](O)[C@@H]([C@H]([C@@H](CC=O)C[C@H]1C)O[C@H]1[C@@H]([C@H]([C@H](O[C@@H]2O[C@@H](C)[C@H](O)[C@](C)(O)C2)[C@@H](C)O1)N(C)C)O)OC)[C@@H]1CC[C@H](N(C)C)[C@@H](C)O1 ACTOXUHEUCPTEW-BWHGAVFKSA-N 0.000 title abstract description 8
- 239000004187 Spiramycin Substances 0.000 title abstract 6
- 229960001294 spiramycin Drugs 0.000 title abstract 6
- 229930191512 spiramycin Natural products 0.000 title abstract 6
- 235000019372 spiramycin Nutrition 0.000 title abstract 6
- 102000004190 Enzymes Human genes 0.000 claims abstract description 45
- 108090000790 Enzymes Proteins 0.000 claims abstract description 45
- 239000011248 coating agent Substances 0.000 claims abstract description 21
- 238000000576 coating method Methods 0.000 claims abstract description 21
- 239000003550 marker Substances 0.000 claims abstract description 9
- 239000007788 liquid Substances 0.000 claims description 63
- 239000000427 antigen Substances 0.000 claims description 25
- 102000036639 antigens Human genes 0.000 claims description 25
- 108091007433 antigens Proteins 0.000 claims description 25
- 239000012530 fluid Substances 0.000 claims description 23
- 102000014914 Carrier Proteins Human genes 0.000 claims description 15
- 108010078791 Carrier Proteins Proteins 0.000 claims description 15
- 238000006243 chemical reaction Methods 0.000 claims description 15
- 108010001336 Horseradish Peroxidase Proteins 0.000 claims description 14
- 241001465754 Metazoa Species 0.000 claims description 14
- 239000003814 drug Substances 0.000 claims description 14
- 239000000203 mixture Substances 0.000 claims description 14
- JQWHASGSAFIOCM-UHFFFAOYSA-M sodium periodate Chemical compound [Na+].[O-]I(=O)(=O)=O JQWHASGSAFIOCM-UHFFFAOYSA-M 0.000 claims description 14
- 238000002156 mixing Methods 0.000 claims description 12
- 210000004408 hybridoma Anatomy 0.000 claims description 11
- 230000001900 immune effect Effects 0.000 claims description 10
- 238000002372 labelling Methods 0.000 claims description 10
- 210000002966 serum Anatomy 0.000 claims description 10
- 241000283973 Oryctolagus cuniculus Species 0.000 claims description 9
- 238000013016 damping Methods 0.000 claims description 8
- 210000004185 liver Anatomy 0.000 claims description 8
- 210000003205 muscle Anatomy 0.000 claims description 8
- 108010058846 Ovalbumin Proteins 0.000 claims description 7
- 229960000796 barbital sodium Drugs 0.000 claims description 7
- FTOAOBMCPZCFFF-UHFFFAOYSA-N barbitone sodium Natural products CCC1(CC)C(=O)NC(=O)NC1=O FTOAOBMCPZCFFF-UHFFFAOYSA-N 0.000 claims description 7
- 229940092253 ovalbumin Drugs 0.000 claims description 7
- 239000011780 sodium chloride Substances 0.000 claims description 7
- FAPWRFPIFSIZLT-UHFFFAOYSA-M sodium chloride Inorganic materials [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 7
- RGHFKWPGWBFQLN-UHFFFAOYSA-M sodium;5,5-diethylpyrimidin-3-ide-2,4,6-trione Chemical compound [Na+].CCC1(CC)C([O-])=NC(=O)NC1=O RGHFKWPGWBFQLN-UHFFFAOYSA-M 0.000 claims description 7
- 241000287828 Gallus gallus Species 0.000 claims description 6
- 239000012141 concentrate Substances 0.000 claims description 6
- 230000008878 coupling Effects 0.000 claims description 6
- 238000010168 coupling process Methods 0.000 claims description 6
- 238000005859 coupling reaction Methods 0.000 claims description 6
- 235000015277 pork Nutrition 0.000 claims description 6
- 238000005070 sampling Methods 0.000 claims description 6
- 210000001519 tissue Anatomy 0.000 claims description 6
- 238000002203 pretreatment Methods 0.000 claims description 5
- 230000028327 secretion Effects 0.000 claims description 5
- FALRKNHUBBKYCC-UHFFFAOYSA-N 2-(chloromethyl)pyridine-3-carbonitrile Chemical compound ClCC1=NC=CC=C1C#N FALRKNHUBBKYCC-UHFFFAOYSA-N 0.000 claims description 4
- WTDHULULXKLSOZ-UHFFFAOYSA-N Hydroxylamine hydrochloride Chemical compound Cl.ON WTDHULULXKLSOZ-UHFFFAOYSA-N 0.000 claims description 4
- 108060003552 hemocyanin Proteins 0.000 claims description 4
- 229940014800 succinic anhydride Drugs 0.000 claims description 4
- 102000002260 Alkaline Phosphatase Human genes 0.000 claims description 3
- 108020004774 Alkaline Phosphatase Proteins 0.000 claims description 3
- 108091003079 Bovine Serum Albumin Proteins 0.000 claims description 3
- 229940098773 bovine serum albumin Drugs 0.000 claims description 3
- 210000005228 liver tissue Anatomy 0.000 claims description 3
- 102000008946 Fibrinogen Human genes 0.000 claims description 2
- 108010049003 Fibrinogen Proteins 0.000 claims description 2
- 108091006905 Human Serum Albumin Proteins 0.000 claims description 2
- 102000008100 Human Serum Albumin Human genes 0.000 claims description 2
- 229940012952 fibrinogen Drugs 0.000 claims description 2
- 238000001514 detection method Methods 0.000 abstract description 10
- 238000012544 monitoring process Methods 0.000 abstract description 2
- 238000012216 screening Methods 0.000 abstract description 2
- 239000000523 sample Substances 0.000 description 26
- 238000002360 preparation method Methods 0.000 description 20
- 238000012360 testing method Methods 0.000 description 18
- 239000000243 solution Substances 0.000 description 17
- PXIPVTKHYLBLMZ-UHFFFAOYSA-N Sodium azide Chemical compound [Na+].[N-]=[N+]=[N-] PXIPVTKHYLBLMZ-UHFFFAOYSA-N 0.000 description 14
- 239000012086 standard solution Substances 0.000 description 11
- 241000699666 Mus <mouse, genus> Species 0.000 description 10
- 239000000758 substrate Substances 0.000 description 10
- 241001494479 Pecora Species 0.000 description 9
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 9
- 238000002835 absorbance Methods 0.000 description 9
- 239000000872 buffer Substances 0.000 description 9
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 8
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 6
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 6
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 6
- 238000004140 cleaning Methods 0.000 description 6
- 238000010790 dilution Methods 0.000 description 6
- 239000012895 dilution Substances 0.000 description 6
- 239000008363 phosphate buffer Substances 0.000 description 6
- 238000004321 preservation Methods 0.000 description 6
- 239000000376 reactant Substances 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- YRNWIFYIFSBPAU-UHFFFAOYSA-N 4-[4-(dimethylamino)phenyl]-n,n-dimethylaniline Chemical compound C1=CC(N(C)C)=CC=C1C1=CC=C(N(C)C)C=C1 YRNWIFYIFSBPAU-UHFFFAOYSA-N 0.000 description 5
- 210000004027 cell Anatomy 0.000 description 5
- 230000036039 immunity Effects 0.000 description 5
- 239000012488 sample solution Substances 0.000 description 5
- AQLJVWUFPCUVLO-UHFFFAOYSA-N urea hydrogen peroxide Chemical compound OO.NC(N)=O AQLJVWUFPCUVLO-UHFFFAOYSA-N 0.000 description 5
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 4
- 229920001213 Polysorbate 20 Polymers 0.000 description 4
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 4
- 239000007979 citrate buffer Substances 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 230000005847 immunogenicity Effects 0.000 description 4
- 238000005259 measurement Methods 0.000 description 4
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 4
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 4
- 239000002244 precipitate Substances 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- 230000035945 sensitivity Effects 0.000 description 4
- 238000005303 weighing Methods 0.000 description 4
- 239000002671 adjuvant Substances 0.000 description 3
- 238000007865 diluting Methods 0.000 description 3
- 230000003053 immunization Effects 0.000 description 3
- 238000011084 recovery Methods 0.000 description 3
- ODIGIKRIUKFKHP-UHFFFAOYSA-N (n-propan-2-yloxycarbonylanilino) acetate Chemical compound CC(C)OC(=O)N(OC(C)=O)C1=CC=CC=C1 ODIGIKRIUKFKHP-UHFFFAOYSA-N 0.000 description 2
- GEYOCULIXLDCMW-UHFFFAOYSA-N 1,2-phenylenediamine Chemical compound NC1=CC=CC=C1N GEYOCULIXLDCMW-UHFFFAOYSA-N 0.000 description 2
- YOETUEMZNOLGDB-UHFFFAOYSA-N 2-methylpropyl carbonochloridate Chemical compound CC(C)COC(Cl)=O YOETUEMZNOLGDB-UHFFFAOYSA-N 0.000 description 2
- 241000143437 Aciculosporium take Species 0.000 description 2
- 206010003445 Ascites Diseases 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 239000008351 acetate buffer Substances 0.000 description 2
- 238000004364 calculation method Methods 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 238000010367 cloning Methods 0.000 description 2
- 230000002860 competitive effect Effects 0.000 description 2
- 238000000502 dialysis Methods 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 238000007710 freezing Methods 0.000 description 2
- 230000008014 freezing Effects 0.000 description 2
- 238000004128 high performance liquid chromatography Methods 0.000 description 2
- 230000028993 immune response Effects 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 238000001819 mass spectrum Methods 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 239000010813 municipal solid waste Substances 0.000 description 2
- 238000012856 packing Methods 0.000 description 2
- 150000003384 small molecules Chemical class 0.000 description 2
- 229910000029 sodium carbonate Inorganic materials 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 108010088751 Albumins Proteins 0.000 description 1
- 102000009027 Albumins Human genes 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 231100000703 Maximum Residue Limit Toxicity 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 206010028470 Mycoplasma infections Diseases 0.000 description 1
- 239000005662 Paraffin oil Substances 0.000 description 1
- 206010035226 Plasma cell myeloma Diseases 0.000 description 1
- 206010068676 Pneumoretroperitoneum Diseases 0.000 description 1
- 208000005727 Retropneumoperitoneum Diseases 0.000 description 1
- 241000191940 Staphylococcus Species 0.000 description 1
- 201000005010 Streptococcus pneumonia Diseases 0.000 description 1
- 241000193998 Streptococcus pneumoniae Species 0.000 description 1
- 241000193996 Streptococcus pyogenes Species 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- 239000004411 aluminium Substances 0.000 description 1
- -1 amino amino Chemical group 0.000 description 1
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical class N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 1
- 238000012870 ammonium sulfate precipitation Methods 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- ALSPKRWQCLSJLV-UHFFFAOYSA-N azanium;acetic acid;acetate Chemical compound [NH4+].CC(O)=O.CC([O-])=O ALSPKRWQCLSJLV-UHFFFAOYSA-N 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 238000010241 blood sampling Methods 0.000 description 1
- 239000006285 cell suspension Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000003636 conditioned culture medium Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000005138 cryopreservation Methods 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 238000003255 drug test Methods 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 230000001804 emulsifying effect Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 238000009313 farming Methods 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 238000002649 immunization Methods 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 230000031700 light absorption Effects 0.000 description 1
- 238000004811 liquid chromatography Methods 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000003120 macrolide antibiotic agent Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000004949 mass spectrometry Methods 0.000 description 1
- 201000000050 myeloid neoplasm Diseases 0.000 description 1
- 238000011587 new zealand white rabbit Methods 0.000 description 1
- NFJCQBGAUBIGKV-UHFFFAOYSA-N nitro dihydrogen phosphate Chemical compound OP(O)(=O)O[N+]([O-])=O NFJCQBGAUBIGKV-UHFFFAOYSA-N 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 244000144977 poultry Species 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 238000012113 quantitative test Methods 0.000 description 1
- 230000003252 repetitive effect Effects 0.000 description 1
- 230000010076 replication Effects 0.000 description 1
- 238000011896 sensitive detection Methods 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 210000004988 splenocyte Anatomy 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Landscapes
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
Description
Claims (7)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 200910237822 CN101839918B (en) | 2009-11-11 | 2009-11-11 | Method for detecting spiramycin and special enzyme-linked immunoassay kit thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 200910237822 CN101839918B (en) | 2009-11-11 | 2009-11-11 | Method for detecting spiramycin and special enzyme-linked immunoassay kit thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101839918A CN101839918A (en) | 2010-09-22 |
CN101839918B true CN101839918B (en) | 2013-07-03 |
Family
ID=42743421
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 200910237822 Expired - Fee Related CN101839918B (en) | 2009-11-11 | 2009-11-11 | Method for detecting spiramycin and special enzyme-linked immunoassay kit thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101839918B (en) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103926399A (en) * | 2011-02-24 | 2014-07-16 | 磁量生技股份有限公司 | Method for detecting veterinary medicine residues in foods |
CN102721808A (en) * | 2011-03-29 | 2012-10-10 | 库尔医疗技术(北京)有限公司 | Spiramycin assay kit and method for making the same |
CN102967709B (en) * | 2011-09-01 | 2015-08-12 | 北京勤邦生物技术有限公司 | Detect enzyme linked immunological kit and the application thereof of zearalenone medicine |
CN103288963B (en) * | 2012-02-29 | 2014-10-15 | 华中农业大学 | Monoclonal antibody for kitasamycin residual detection and preparation method and application thereof |
CN103713133B (en) * | 2012-09-29 | 2016-06-22 | 北京勤邦生物技术有限公司 | Detection spiramycin, streptomycin, gentamycin, the test strips of neomycin and method |
CN104280557B (en) * | 2014-09-29 | 2016-09-21 | 贵州勤邦食品安全科学技术有限公司 | A kind of detection avilamycin enzyme linked immunological kit and preparation method thereof and detection method |
CN108548918B (en) * | 2018-04-19 | 2022-04-15 | 国家食品安全风险评估中心 | Enzyme-linked immunosorbent assay blocking solution, preparation method, application and kit with enzyme-linked immunosorbent assay blocking solution |
CN108254560A (en) * | 2018-04-19 | 2018-07-06 | 国家食品安全风险评估中心 | Aflatoxins M1 high-throughput enzyme linked immunoassay reagent kit and its detection method in milk |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101021535B (en) * | 2007-03-12 | 2011-06-22 | 北京望尔康泰生物技术有限公司 | Enzyme-linked immunalogical kit for detecting gentamicin medicine and method |
CN101256188B (en) * | 2008-04-16 | 2012-07-11 | 北京望尔生物技术有限公司 | ELISA kit for detecting lincomycin medicine as well as usage thereof |
-
2009
- 2009-11-11 CN CN 200910237822 patent/CN101839918B/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CN101839918A (en) | 2010-09-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101839918B (en) | Method for detecting spiramycin and special enzyme-linked immunoassay kit thereof | |
CN101256188B (en) | ELISA kit for detecting lincomycin medicine as well as usage thereof | |
CN100403030C (en) | ELISA kit for detecting Sudan red medicines and detection method thereof | |
CN101571539B (en) | Elisa kit for detecting cephalo-type medicine and application thereof | |
CN101413943B (en) | Method for detecting melamine and specific enzyme-linked immunologic reagent kit | |
CN102967709B (en) | Detect enzyme linked immunological kit and the application thereof of zearalenone medicine | |
CN101776685B (en) | Enzyme linked immunosorbent assay kit for detecting trimethoprim medicament and application thereof | |
CN102080066B (en) | Method for detecting T-2 toxin and special reagent kit thereof | |
CN101571540B (en) | Enzyme-linked immunosorbent kit for inspecting porcine immunoglobulin G and application thereof | |
CN101571541A (en) | Enzyme-linked immunosorbent inspect kit for inspecting sulfa drugs and method thereof | |
CN100501409C (en) | ELISA kit for detecting chloramphenicols in animal derived food | |
CN101358967B (en) | Method for detecting chlorpromazine and special ELISA kit thereof | |
CN101299046B (en) | Method for detecting erythromycin series compounds and special-purpose enzyme-linked immunologic reagent kit thereof | |
CN101315378B (en) | Method and special ELISA reagent kit for detecting nitryl imidazole medicament | |
CN102080067B (en) | Method for detecting deoxynivalenol and special reagent kit thereof | |
CN101358966B (en) | Method for detecting colimycin and special ELISA kit thereof | |
CN101299045B (en) | Method for detecting florfenicol and florfenicol amine and special-purpose enzyme-linked immunologic reagent kit thereof | |
CN102079789A (en) | Method for detecting maduramicin and special enzyme-linked immunoassay reagent kit thereof | |
CN101329339A (en) | Method for testing cattle immune globulin G and special-purpose enzyme-linked immunologic reagent kit thereof | |
CN101349693A (en) | Fluorobenzene niekau series medicament fast detecting reagent kit and uses thereof | |
CN101782579B (en) | Enzyme-linked immunoassay kit for detecting tiamulin medicaments, and application thereof | |
CN100582778C (en) | Method for detecting Ivermectin and special enzyme-linked immune reagent kit thereof | |
CN102565399B (en) | Method for detecting hydrocortisone and special enzyme-linked immunosorbent assay kit thereof | |
CN103364553A (en) | Enzyme linked immunosorbent assay kit for detecting nitroimidazole drugs and application thereof | |
CN100489532C (en) | Method for detecting salinomycin and spcial enzyme-linked immune reagent kit thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
ASS | Succession or assignment of patent right |
Free format text: FORMER OWNER: BEIJING WANGER BIOTECHNOLOGY CO., LTD. Effective date: 20120518 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 102206 CHANGPING, BEIJING TO: 100193 HAIDIAN, BEIJING |
|
TA01 | Transfer of patent application right |
Effective date of registration: 20120518 Address after: 100193 Beijing city Haidian District Old Summer Palace West Hospital No. 2 room 10 Applicant after: Beijing Wanger Biotechnology Co.,Ltd. Address before: 102206 Beijing city Changping District Huilongguan international information industry base, four High Street No. 8 Applicant before: Beijing Wanger Kangtai Biotechnology Co.,Ltd. Co-applicant before: Beijing Wanger Biotechnology Co.,Ltd. |
|
ASS | Succession or assignment of patent right |
Owner name: GUIZHOU QINBANG FOOD SAFETY SCIENCE AND TECHNOLOGY Free format text: FORMER OWNER: BEIJING WANGER BIOTECHNOLOGY CO., LTD. Effective date: 20130605 |
|
C14 | Grant of patent or utility model | ||
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 100193 HAIDIAN, BEIJING TO: 550009 GUIYANG, GUIZHOU PROVINCE |
|
GR01 | Patent grant | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20130605 Address after: 550009, Guizhou province Guiyang Xiaohe Industrial Park standard factory building No. two, building 1, building 1-2 Applicant after: GUIZHOU KWINBON SCIENCE AND TECHNOLOGY FOR FOOD SAFETY Co.,Ltd. Address before: 100193 Beijing city Haidian District Old Summer Palace West Hospital No. 2 room 10 Applicant before: Beijing Wanger Biotechnology Co.,Ltd. |
|
DD01 | Delivery of document by public notice |
Addressee: Tao Guangcan Document name: payment instructions |
|
DD01 | Delivery of document by public notice | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20130703 Termination date: 20211111 |
|
CF01 | Termination of patent right due to non-payment of annual fee |